PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 23, 1984New England Journal of Medicine298 citations

Monoclonality of Lymphoproliferative Lesions in Cardiac-Transplant Recipients

View Full Paper
MCMichael L. ClearyRWRoger A. WarnkeJSJeffrey Sklar

Key Points

Key points are not available for this paper at this time.

Abstract

Whether lymphoproliferative disorders arising in immunosuppressed recipients of organ transplants are primarily neoplastic or hyperplastic in nature is a matter of controversy. Reports of polyclonal B-cell proliferations in these lesions suggest the presence of hyperplasia, but these disorders resemble lymphoma histologically and are clinically aggressive and often rapidly fatal, as expected of a malignant neoplastic disease. We examined tissue specimens from 10 cases of lymphoproliferative disease that occurred in immunosuppressed recipients of cardiac transplants. Specimens from nine of these patients lacked cellular immunoglobulin; however, analysis of DNA extracted from these tissues revealed that each lesion contained large numbers of cells possessing uniform, clonal rearrangements of immunoglobulin-gene DNA. Therefore, when first seen clinically these proliferations contained a notable monoclonal-cell population typical of conventional B-cell lymphomas that are not associated with immunosuppression. We therefore suggest that lymphoproliferative disorders in recipients of cardiac transplants are neoplastic at the earliest stages of detectable disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cleary et al. (1984) studied this question.

synapsesocial.com/papers/6a813fe8fd865eccc665fcd5https://doi.org/10.1056/nejm198402233100801
Ask AI
Helpful
Bookmark
Share
View Full Paper